Drug Type Oligonucleotide |
Synonyms FAD program (Vico Therapeutics) |
Target |
Mechanism PSEN1 modulators(presenilin 1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization VICO Therapeutics BVStartup |
Active Organization VICO Therapeutics BVStartup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Discovery | NL | VICO Therapeutics BVStartup | 06 Oct 2024 |